NovaBay Pharmaceuticals, Inc. - NBY
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 09, 2026 | — | A | A | 140,000.0 | 0.0 | 0.0 | 140,000.0 | View | |
| Apr 08, 2026 | Chief Financial Officer | A | A | 300,000.0 | 0.0 | 0.0 | 300,000.0 | View | |
| Apr 02, 2026 | Chief Executive Officer | A | A | 7,722,802.0 | 0.0 | 0.0 | 7,722,802.0 | View | |
| Apr 02, 2026 | Chief Executive Officer | A | A | 4,118,828.0 | 0.0 | 0.0 | 4,118,828.0 | View | |
| Apr 02, 2026 | — | A | A | 140,000.0 | 0.0 | 0.0 | 140,000.0 | View | |
| Jan 29, 2026 | — | M | D | 39,925.0 | — | — | 0.0 | View | |
| Jan 29, 2026 | — | A | A | 6,388,000.0 | — | — | 6,388,000.0 | View | |
| Nov 03, 2025 | — | P | A | 2,702,703.0 | 0.0 | 0.0 | 2,702,703.0 | View | |
| Nov 03, 2025 | — | C | A | 56,806,080.0 | 0.0 | 0.0 | 56,806,080.0 | View | |
| Nov 03, 2025 | — | P | A | 2,702,703.0 | 0.0 | 0.0 | 2,702,703.0 | View | |
| Nov 03, 2025 | — | C | A | 56,806,080.0 | 0.0 | 0.0 | 56,806,080.0 | View | |
| Nov 03, 2025 | Chief Executive Officer | P | A | 2,702,703.0 | 0.0 | 0.0 | 2,702,703.0 | View | |
| Nov 03, 2025 | Chief Executive Officer | C | A | 56,806,080.0 | 0.0 | 0.0 | 56,806,080.0 | View |